1. Home
  2. TRVI vs WGO Comparison

TRVI vs WGO Comparison

Compare TRVI & WGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRVI
  • WGO
  • Stock Information
  • Founded
  • TRVI 2011
  • WGO 1958
  • Country
  • TRVI United States
  • WGO United States
  • Employees
  • TRVI N/A
  • WGO N/A
  • Industry
  • TRVI Biotechnology: Pharmaceutical Preparations
  • WGO Homebuilding
  • Sector
  • TRVI Health Care
  • WGO Industrials
  • Exchange
  • TRVI Nasdaq
  • WGO Nasdaq
  • Market Cap
  • TRVI 1.1B
  • WGO 893.6M
  • IPO Year
  • TRVI 2019
  • WGO N/A
  • Fundamental
  • Price
  • TRVI $10.65
  • WGO $29.96
  • Analyst Decision
  • TRVI Strong Buy
  • WGO Buy
  • Analyst Count
  • TRVI 9
  • WGO 12
  • Target Price
  • TRVI $20.72
  • WGO $39.36
  • AVG Volume (30 Days)
  • TRVI 2.0M
  • WGO 498.5K
  • Earning Date
  • TRVI 11-05-2025
  • WGO 10-22-2025
  • Dividend Yield
  • TRVI N/A
  • WGO 4.67%
  • EPS Growth
  • TRVI N/A
  • WGO N/A
  • EPS
  • TRVI N/A
  • WGO N/A
  • Revenue
  • TRVI N/A
  • WGO $2,741,800,000.00
  • Revenue This Year
  • TRVI N/A
  • WGO N/A
  • Revenue Next Year
  • TRVI N/A
  • WGO $5.80
  • P/E Ratio
  • TRVI N/A
  • WGO N/A
  • Revenue Growth
  • TRVI N/A
  • WGO N/A
  • 52 Week Low
  • TRVI $2.36
  • WGO $28.00
  • 52 Week High
  • TRVI $11.11
  • WGO $65.65
  • Technical
  • Relative Strength Index (RSI)
  • TRVI 71.22
  • WGO 35.80
  • Support Level
  • TRVI $9.29
  • WGO $29.24
  • Resistance Level
  • TRVI $10.04
  • WGO $31.18
  • Average True Range (ATR)
  • TRVI 0.57
  • WGO 1.17
  • MACD
  • TRVI 0.07
  • WGO -0.35
  • Stochastic Oscillator
  • TRVI 82.67
  • WGO 12.29

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

About WGO Winnebago Industries Inc.

Winnebago Industries manufactures Class A, B, and C motor homes along with towables, customized specialty vehicles, boats, and parts. Headquartered in Eden Prairie, Minnesota, Winnebago has been producing recreational vehicles since 1958. Revenue was nearly $3 billion in fiscal 2024. Winnebago expanded into towables in 2011 with the acquisition of SunnyBrook and acquired Grand Design in November 2016. Towables made up 83% of the firm's RV unit volume, up from 31% in fiscal 2016. The company's total RV unit volume was 38,796 in fiscal 2024. Winnebago expanded into boating in 2018 with the purchase of Chris-Craft, bought premium motor home maker Newmar in November 2019, and bought Barletta pontoon boats in August 2021. It also is developing electric and autonomous technology.

Share on Social Networks: